September 2026
The U.S. systemic inflammatory response syndrome treatment market generated USD 5.28 billion in 2026, with prominent U.S. systemic inflammatory response syndrome treatment market companies including GlaxoSmithKline, AstraZeneca, CytoSorbents Corporation.
July 2026
The global systemic inflammatory response syndrome treatment market size is estimated to hit around USD 25.84 billion by 2035 increasing from USD 14.89 billion in 2025, with a CAGR of 5.98%.
September 2026
The U.S. non-invasive aesthetic treatment market size totalled USD 8.72 billion in 2026, with major U.S. non-invasive aesthetic treatment market players including galderma sa, allergen, alma lasers, lumenis, merz pharma.
September 2026
The U.S. diabetic foot ulcer treatment market generated USD 3.87 billion in 2026, with prominent U.S. diabetic foot ulcer treatment market companies including 3M / Solventum, Smith+Nephew, Mölnlycke Health Care.
July 2026
The global polycystic ovarian syndrome treatment market size was evaluated at USD 4.84 billion in 2024 and is predicted to hit around USD 9.21 billion by 2034, growing at a CAGR of 6.64%.
April 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
March 2026
The global systemic mastocytosis treatment market size is expected to increase from USD 562.18 million in 2025 to hit around USD 1,326.01 million by 2035, growing at a CAGR of 8.96%.
June 2025
The U.S. water and wastewater treatment market size is estimated to hit around USD 123.76 billion by 2034, increasing from USD 64.27 billion in 2024, with a CAGR of 6.80%.
September 2026
The U.S. regenerative medicine market was worth USD 24.10 billion in 2026, with key U.S. regenerative medicine market players including Integra LifeSciences Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), American CryoStem Corporation (U.S.).
September 2026
The U.S. clinical trial supply and logistics market was worth USD 1.66 billion in 2026, with key U.S. clinical trial supply and logistics market players including Marken, World Courier, Fisher Clinical Services.
August 2026
The U.S. blood pressure monitoring devices market size reached USD 775.58 billion in 2026, with leading U.S. blood pressure monitoring devices market companies including Koninklijke Philips N.V., General Electric Company, SunTech Medical, Inc.
June 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The U.S. buy now pay later market reached USD 6.01 billion in 2026, with key U.S. buy now pay later companies including sizzle, zip co limited, splitit payments ltd, affirm holdings inc, paypal holdings inc, perpay.
September 2026
The U.S. pharmacy benefit management market was valued at USD 504.08 billion in 2026, with leading companies including Cigna Group, CVS Health, MedImpact.
September 2026
The U.S. pain management drugs market reached USD 33.84 billion in 2026, with key U.S. pain management drugs companies including abbott, Pfizer, teva pharmaceutical, endo international, depomed, merck.
September 2026
The Healthcare Consumables market was valued at USD 49.33 billion in 2026, with leading companies including boston scientific corporation, 3m, johnson & johnson, Medtronic, bd.
September 2026
The U.S. insulin pump market generated USD 2.48 billion in 2026, with prominent U.S. insulin pump market companies including Medzer, Cequr SA, Medtronic.
September 2026
The U.S. perfusion system market generated USD 7,35,773.48 thousand in 2026, with prominent U.S. perfusion system market companies including Medtronic plc, Getinge AB, LivaNova PLC.
September 2026
The U.S. central lab market generated USD 2.58 billion in 2026, with prominent U.S. central lab market companies including IQVIA, Labcorp, Quest Diagnostics, Thermo Fisher Scientific.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The U.S. biologics market was worth USD 223.60 billion in 2026, with key U.S. biologics market players including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche.
September 2026
The U.S. healthcare cloud computing market was worth USD 27.74 billion in 2026, with key U.S. healthcare cloud computing market players including Amazon Web Services (AWS), Microsoft, Google.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The U.S. personalized medicine market generated USD 207.15 billion in 2026, with prominent U.S. personalized medicine market companies including Thermo Fisher Scientific, Illumina, Johnson and Johnson.
September 2026
The biological treatment technologies market was valued at USD 3.33 billion in 2026, with leading companies including Scarab International, Alfa Laval, Pentair PLC, Evoqua Water Technology.
September 2026
The U.S. digital health in neurology market size was USD 19.98 billion in 2026, with leading U.S. digital health in neurology market players including Teladoc, Proteus, Digital Health, Omada Health, Blackrock Neurotech
September 2026
The U.S. over the counter (OTC) drugs market size stood at USD 26 billion in 2026, with major U.S. over the counter (OTC) drugs companies including bayer ag, Pfizer, johnson & johnson services inc, Sanofi sa, Novartis ag.
September 2026
The U.S. brain computer interface market size stood at USD 703.70 billion in 2026, with major U.S. brain computer interface companies including neurosky, emotive, integra lifesciences, cortech solutions, cadwell industries.
September 2026
The U.S. biofuels market size stood at USD 53.92 billion in 2026, with major U.S. biofuels companies including Cargill, DowDuPont inc, archer daniels midland company, butamax advances biofuels llc, lanzajet inc.
September 2026
The hemophilia treatment market was valued at USD 23.23 billion in 2026, with leading companies including Shire, CSL Behring, Grifols, S.A., Biogen Inc..
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com